Search Results 951-960 of 91001 for Metastasis
A Study of Doxorubicin Plus Olaratumab (LY3012207) in Participants With Advanced or Metastatic Soft Tissue Sarcoma · Share · Facebook · Twitter.
... metastasis, cardiovascular diseases, VEGF , cell signaling, and related studies. ... Our lab has six main research projects, focusing on angiogenesis and its role ...
Alisertib With or Without Fulvestrant in Treating Patients With Locally Advanced or Metastatic, Endocrine-Resistant Breast Cancer · Overview · Participation ...
... metastatic DD liposarcoma that progressed on 1 or more prior systemic ... metastases are present; ≤ 5 × ULN if liver metastases are present. Total ...
... Metastatic Vertebral Body Tumor(s) Rochester, MN. The purpose of this study is to evaluate treating painful metastatic lesions in vertebral bodies with ...
Bidirectional treatment for metastatic gastric cancer. When stomach cancer metastasizes, it most often spreads to the peritoneum. In the past, the prognosis for ...
... metastatic breast cancer. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or ...
... metastatic breast cancer. The names of the study drugs involved in this ... A Study to Collect Clinical Data, Blood Samples, and Tissue Specimens from Patients ...
... metastatic NSCLC with histologically confirmed (squamous or nonsquamous) KRASG12C mutation and histologically confirmed PD-L1 TPS ≥ 1%. - Cohort C: Has an ...
... metastatic breast cancer that has progressed on treatment with everolimus in ... metastatic breast cancer after progression on previous endocrine ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.